Tandem Health Lands $100M to Develop AI Clinic OS

The big picture: Tandem Health, a Stockholm-based healthtech startup, has raised $100 million in Series B funding, bringing its total capital to $160 million. The round was led by EQT’s Scaleup Europe Fund, marking its first investment in the healthcare sector. Tandem Health’s AI scribe is currently deployed in 10,000 care organizations across 14 European countries. Tandem Health aims to expand its offerings beyond its AI medical assistant to develop an AI Clinic Operating System.

Why it matters:

• Healthcare Strain: Europe faces a projected shortfall of 1.6 million health and social care workers this year, potentially rising to 4 million by 2030, exacerbated by an aging population.
• Market Growth: The generative AI market for clinical documentation, where Tandem operates, is forecast to grow from $1.05 billion in 2026 to $10.5 billion by 2034.
• European Focus: Tandem provides an alternative to legacy or US-centric AI solutions, specifically designed for Europe’s fragmented and highly regulated health systems.

How it works:

• AI Scribe: Tandem’s assistant automates clinical notes, suggests billing codes, and offers clinical decision support, streamlining administrative tasks for clinicians.
• Certified Tools: Its AI scribe, coding assistant, and clinical decision support tools are certified as Class IIa medical devices under the EU’s Medical Device Regulation, a more rigorous process than many competitors.
• Future Vision: The company plans to develop an AI Clinic Operating System that integrates patient-flow management with its existing scribe and coding capabilities.

The catch: Tandem Health faces competition from European players like Nabla and Heidi Health, which emphasize speed and low cost. While US-based Abridge has raised significantly more capital, its solutions are tailored for the US market’s regulatory and reimbursement conditions. Tandem’s strategy of careful, market-by-market certification in Europe’s fragmented health systems is a differentiator, but the ultimate challenge will be gaining trust for an AI system to manage patient flow.